Methods
This study was conducted in compliance with the institutional review boards of the University of North Carolina, Chapel Hill; and the Durham Veterans Affairs Medical Center.
SUBJECTS
A cross-sectional sample was composed of individuals enrolled in the Johnston County Osteoarthritis Project, an ongoing study of the occurrence of knee and hip osteoarthritis in a rural, biracial population of North Carolina. Details of this study have been reported. 13 Briefly, this study involved civilian, noninstitutionalized adults aged 45 years and older who resided in 6 townships in Johnston County. Participants were recruited by probability sampling, with oversampling of African Americans. The sample for this analysis included individuals who had participated in either the first follow-up of the study conducted between 1999 and 2004 (n = 1733) or had been newly enrolled in 2003 or 2004 (n = 1015). New individuals were enrolled to enrich the sample for African Americans and younger individuals who were deliberately targeted for inclusion. As such, the newly enrolled participants were younger (mean age 65.8 y and 59.3 y in first follow-up and newly enrolled subsample, respectively) and more likely to be African American (28% vs 40%). For these analyses, 49 participants did not complete the sleep problem and sleep medication questions and were excluded, leaving 2699 (98% of the total sample of 2748: 1703 participants from the first follow-up and 996 from the newly enrolled group).
SLEEP PROBLEM QUESTIONS
We examined the use of sleep medications among the subsample of participants who reported having a current sleep problem. Questions about sleep problems were adapted from the Medical Outcomes Study sleep questionnaire. 14 The validity and reliability of the Medical Outcomes Study sleep items have been established in a nationally representative sample of US adults. 15 Participants were asked, "Have you ever been troubled by any of the following problems?" These included trouble falling asleep, waking up during the night, waking up early and not being able to fall asleep again, falling asleep during the day, not getting enough sleep, and not feeling rested upon awakening in the morning. If participants indicated that they had ever been troubled by any of these 6 sleep problems, they were further asked whether they "currently have" that sleep problem. We considered participants to have a current sleep problem if they indicated that they reported one or more of these sleep problems at the time of the survey. Additional details regarding the prevalence of specific sleep problems have been reported. 16 We were also interested in assessing the frequency of participants' current sleep problems as an indicator of severity, since this may be associated with the use of sleep medications. Participants were asked the frequency (number of times per week) of each of the 6 sleep problems. If they had the sleep problem less than once per week, they were asked how many times per month; if less than once per month, they were asked how many times per year. From these data, we computed the annual frequency (total number of days per year) that participants reported being troubled by each of the sleep problems. Because of the similarity among some of the sleep questions, leading to possible problems with multicollinearity in multivariable models, we combined these items into 2 broader categories: insomnia (comprising trouble falling asleep, waking during the night, waking early) and insufficient sleep (comprising falling asleep during the day, not getting enough sleep, not feeling rested). The insomnia and insufficient sleep categories and their component questions were based on previous definitions of sleep disturbances. 17 For each participant, we calculated the mean annual days of sleep problems in these 2 categories.
SLEEP MEDICATION QUESTIONS
Participants were asked whether they were currently taking each of the following to help them sleep: prescription any, nonprescription (over-the-counter) medications, herbal medications, and other medications. (No specific examples of other sleep medications were provided to participants, but participants were permitted to report any drug they were taking to help them sleep.) We examined each of these categories separately and also created a composite variable indicating whether participants were taking any of these types of medication.
DEMOGRAPHIC AND CLINICAL CHARACTERISTICS
In addition to self-reported race (African American vs white), we also examined the following 10 participant characteristics as covariates because they have been associated with race, sleep problems, and/or medication use in some previous research: age, sex, education (2:12 vs <12 y), having any type of health insurance (yes or no), obesity (defined as body mass index [BMI] 2:30), depressive symptoms (defined as a Center for Epidemiologic Studies Depression Scale score 2:16), self-rated health compared with other people the same age ("Compared to other people of your age, how would you say your health is?"; categorized as excellent or good vs fair or poor), symptomatic hip or knee osteoarthritis, mean annual days of insomnia, and mean annual days of insufficient sleep (as described above). 17 " 23 Height without shoes was measured in centimeters and weight was measured in kilograms using a balance beam scale; BMI was calculated as kilograms per square meter. All participants underwent posteroanterior radiography of both knees with weight-bearing, using the SynaFlex positioning frame (Synarc Inc., San Francisco, CA). Supine anterior-posterior pelvis films were obtained for all men and women 50 years of age and older. All radiographs were read for Kellgren-Lawrence (K-L) score by a single bone and joint radiologist (JBR), without regard to a participant's clinical status. Previous assessment showed interrater and intrarater reliability of the radiologist to be high (weighted K = 0.9). 24 Radiographic knee or hip osteoarthritis was defined as a K-L grade 2 or greater in at least one knee or hip. Participants were asked, "On most days, do you have pain, aching, or stiffness in your... right/left hip/knee?" We defined symptomatic hip or knee osteoarthritis as the presence of both radiographic osteoarthritis and joint symptoms in the same joint.
ANALYSES
Because few participants reported using herbal and other sleep medications, we did not analyze these categories separately, x 2 Tests were used to examine bivariate associations of participant race with the use of any type of sleep medication, prescription sleep medication, or nonprescription sleep medication. Next, we conducted multiple logistic regression models examining the association of race with use of any type of sleep medication, prescription sleep medication, and nonprescription sleep medication, controlling for the 10 covariates described above. Because prior research has shown that there are differences in medication use in general according to sex, we examined whether racial differences in sleep medication use varied according to sex. 25 While a cross-product term of the interaction of race and sex was not statistically significant in multivariable logistic models (p values = 0.12-0.25), there can be still meaningful additive interactions between variables. 26 We therefore conducted the analyses described above separately for men and women. To further explore the nature of potential interactions of race and sex, we examined associations between sex and sleep medication use among African American and white participants separately. All statistical analyses were performed using SAS PC, Version 9 (SAS Inc., Cary, NC). Any cases with missing data for variable(s) in a statistical model were deleted from that analysis. Missing data were minimal (Table 1 footnote).
Results
Among the sample of 2699 participants, 1910 (71%) reported having current sleep problems and were included in these analyses. Of those reporting current problems, 58% reported symptoms of both insomnia and insufficient sleep, 21% reported symptoms of insomnia only, and 21% reported symptoms of insufficient sleep only. Demographic and clinical characteristics of the study sample are presented in Table 1 . Among this sample, 31 % (n = 597) were using any type of sleep medication, 17% (n = 332) were using prescription sleep medications, 12% (n = 236) were using nonprescription sleep medications, 1 % (n = 28) were using herbal sleep medications, and 3% (n = 56) were using other sleep medications. Some participants (n = 50) indicated using more than one category of sleep medication. Among those using other sleep medications, the most commonly reported were pain and arthritis drugs (n = 21), antidepressants (n = 6), antianxiety medications (n = 5), and muscle relaxants (n = 4).
African Americans in our study were significantly older, had a higher proportion of females, had a lower proportion of high school graduates and individuals with health insurance, and were more likely to be obese and to report depressive symptoms and fair or poor general health (Table  1) . African Americans on average reported fewer days of insomnia symptoms and more days of insufficient sleep 
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The Annals of Pharmacotherapy ■ 2008 September, Volume 42 ■ 1241 symptoms compared with whites, but neither of these differences was statistically significant. African Americans were less likely than whites to be using any type of sleep medication (p < 0.001), prescription sleep medication (p = 0.003), and nonprescription sleep medication (p = 0.048). In a multivariate model including the 10 covariates (Table 2) , African Americans were significantly less likely to report current use of any type of sleep medication. The following groups were significantly more likely to report current use of any sleep medication: females, those with health insurance, those with greater mean annual days of insomnia, and those with symptomatic hip or knee osteoarthritis, more depressive symptoms, and fair or poor general health.
African Americans were significantly less likely to report using prescription sleep medications when all other covariates were controlled for ( Table 2 ). The following were significantly more likely to report using prescription sleep medications: females, those with health insurance, those with greater mean annual days of insomnia and insufficient sleep, and those with symptomatic hip or knee osteoarthritis, depressive symptoms, and fair or poor health; participants 55-64 years of age were less likely than those 45-54 years of age to report using prescription sleep medication.
African Americans were also significantly less likely to report using nonprescription sleep medications in the multivariable model ( Table 2 ). The only other factor significantly associated with use of nonprescription sleep medication was greater number of days of insomnia; depression was of borderline significance (p = 0.052).
Among women in the sample, significantly lower proportions of African Americans than whites reported using any type of sleep medication (26% vs 38%, respectively; p < 0.001), prescription sleep medication (14% vs 21%, respectively; p = 0.002), and nonprescription sleep medication (11% vs 15%, respectively; p = 0.031). In multivariable models controlling for the 9 other covariates (Table  3) , African American women were significantly less likely than white women to report using any type of sleep medication, prescription sleep medication, and nonprescription sleep medication Among men there were no significant racial differences in use of any type of sleep medication (African American 22%, white 27%), prescription sleep medication (African American 12%, white 15%), or nonprescription sleep medication (African American 10%, white 11%). In multivariate models controlling for the 9 other covariates (Table 4 ), African American men had lower odds compared with white men of reporting use of any type of sleep medication, prescription sleep medication, and nonprescription sleep medication, but none of these racial differences was statistically significant.
Among African Americans in the sample, there were no significant differences by sex in use of any type of sleep medication (males 22%, females 26%), prescription sleep medication (males 12%, females 14%), or nonprescription sleep medication (males 10%, females 11%). There were also no significant differences by sex in sleep medication use among African Americans in multivariable models controlling for other covariates. Among whites in the sample, significantly lower proportions of males than females reported using any type of sleep medication (27% vs 38%, respectively; p < 0.001), prescription sleep medication (15% vs 21%, respectively; p = 0.005), and nonprescription sleep medication (11% vs 15%, respectively; p = 0.036). In multivariable models controlling for the 9 other covariates, white women were significantly more likely than white men to report using any type of sleep medication (OR 1.68, 95% CI 1.29 to 2.21), prescription sleep medication (OR 1.55, 95% CI 1.11 to 2.17), and nonprescription sleep medication (OR 1.53, 95% CI 1.05 to 2.23).
Discussion
This study examined the association of race with the use of sleep medications among individuals in a community sample. Of the total sample, a relatively high proportion (71%) reported having some type of current sleep problem. Among those with self-reported sleep problems, 31% reported current use of some type of sleep medication. African Americans were less likely than whites to be taking any type of sleep medication, including prescription or 
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The Annals of Pharmacotherapy ■ 2008 September, Volume 42 ■ 1243 nonprescription, even when controlling for important demographic and clinical characteristics and annual frequency of sleep problems. These racial differences are consistent with findings from previous studies among patients seeking treatment for sleep problems and a general sample of adults not selected for having sleep problems. 7, 9 However, we also found that these racial differences were significant among women but not among men.
There are many possible factors that could underlie racial differences in sleep medication use. First, prior research has shown that African Americans use fewer medications in general than whites 12 ; other research indicates that even when studies include patients who are diagnosed with specific conditions, African Americans are less likely than whites to take or be prescribed drugs for that illness. 27, 28 Second, there may be racial differences in prescription drug insurance, which could influence the availability or out-of-pocket cost of medications used for treating sleep problems. However, previous research has shown that some racial differences in medication use persist when adjusting for prescription drug insurance, and income appears to be a more important contributing factor. 29 Third, patient preferences may contribute to these racial differences. While racial differences in the perception of sleep medications have not been previously examined, racial differences in the willingness to use other treatments have. For example, one study found that African Americans were less likely than whites to perceive use of antidepressants as acceptable. 30 Stratified analyses also showed that racial differences in sleep medication use were significant for women but not for men. The larger sample size among women may have made it more likely to observe a statistically significant racial difference in this group compared with men. However, the magnitude of the racial difference in sleep medication use was clearly larger for women than for men. Specifically, white women had greater use of sleep medication (38%) than any of the other race/sex groups (22-27%) . Further, there were significant differences by sex in sleep medication use among whites but not among African Americans. These results suggest that the observed overall differences by race and sex in sleep medication use were strongly driven by use in white women.
Symptomatic hip or knee osteoarthritis, depressive symptoms, fair/poor self-reported health, and female sex were also associated in multivariable models with greater likelihood of using sleep medications. These results extend the findings of prior research, in which each of these variables has been associated with the presence of sleep problems and/or greater odds of sleep medication use. 5^ '17,18,20,21 These factors may be associated with greater severity of sleep problems, leading to greater likelihood of medication use. Although we controlled for mean annual days of sleep insomnia and insufficient sleep, there may be other aspects of severity that we did not capture. In these models, insomnia symptoms (ie, trouble with falling or staying asleep) had a slightly stronger association with use of sleep medications than did symptoms of insufficient sleep (ie, feeling sleepy or unrefreshed during the day).
This study is one of the few to report the prevalence of sleep medication use among individuals with current sleep problems. The prevalence of prescription drug use in this study was much lower than in the National Ambulatory Medical Care Survey (17% vs 63%), probably because the ambulatory care survey included only patients who were currently seeking physician care for sleep problems, whereas our study involved a more general community sample that may have included individuals with less severe sleep problems. 7 Strengths of this research include the large, community sample, use of multiple sleep questions, and inclusion of key covariates that have been associated with sleep problems and/or medication use in previous studies. There are some limitations related to data on sleep problems. First, there is generally a lack of consensus on how to define and identify sleep problems, particularly in large-scale epidemiologic studies. Second, we did not measure all aspects of sleep problem severity, such as how long it takes individuals to fall asleep or how many times they wake up at night. Third, participants were asked whether they had any current sleep problems, but we did not specify a timeframe, and participants may have differed in their interpretation of the term current. Fourth, since we assessed the use of sleep medications only among participants who reported having current sleep problems, we may have excluded individuals who had sleep problems that were well controlled by current medication use (and therefore did not report current sleep problems). However, there were only 84 individuals (3% of total sample) who reported using sleep medications but did not report current sleep problems. We chose to focus only on those who reported current sleep problems because this approach includes a cleaner sample of individuals for whom there is a clear indication to consider the use of sleep medications. Inclusion of individuals who did not report current sleep problems but did report taking sleep medications would likely have supported (or even strengthened) the observed racial differences, since among those who did not report current sleep problems, the proportion of those who reported taking sleep medications was higher among whites than African Americans (13% vs 4%, respectively). Fifth, sleep medication use was assessed by participant self-report, and pharmacy records were not available. However, our analyses were restricted to current (not historical) medication use, which should minimize inaccuracies in self-reporting. This study was also limited to white and African American participants and those over age 45 years (including a sam-pie enriched for younger individuals in this age range). This may limit the generalizability of the findings, and additional study is needed among other racial and ethnic groups as well as other age groups.
Conclusions
In summary, among this sample of individuals with selfreported sleep problems, African Americans were less likely than their white counterparts to be using prescription and nonprescription sleep medications, even when we controlled for other important demographic and clinical covariates. However, these results appeared to be largely driven by racial differences among women. Additional research should examine possible reasons for these differences in sleep medication use, including racial differences in sleep patterns and perceptions of sleep problem severity, physician prescribing patterns, patient preferences for nonpharmacologic therapies, acceptability of using sleep medications, and willingness to pay for sleep medications. Research should also examine whether racial differences in sleep medication use have any impact on short-or longterm clinical outcomes of sleep problems. OBJETTVO: Este estudio compar6 el uso de medicamentos para dormir entre la poblaci6n afroamericana y blanca que autoreport6 tener actualmente problemas para dormir.
METODO: Los participantes fueron 1910 individuos (69% mujeres, 34% afroamericanos, 66% blancos) del Proyecto de Osteoartritis del Condado de Johnston. Se evaluaron las diferencias raciales en la utilizacidn autoreportada de medicamentos de receta, sin receta, hierbas medicinales, y otros medicamentos utilizados para dormir. Se utilizaron modelos multivariados de regresi6n logfstica controlados para edad, genera, nivel educativo, seguro de salud, osteoartritis sintomdtica de la cadera o la rodilla, sintomas de depresi<5n, obesidad, estado general de salud aceptable o pobre, y el numero autoreportados de dfas al ano con problemas para dormir. Los modelos se realizaron para toda la muestra y para hombres y mujeres por separado.
RESULTADOS: Entre los que tenfan problemas existentes para dormir, 31 % estaban utilizando uno o mas tipos de medicamentos para dormir; 17% estaban utilizando medicamentos para dormir de receta, 12% estaban utilizando medicamentos para dormir sin receta, 1% estaba utilizando hierbas medicinales, y 3% estaban utilizando otros medicamentos para dormir. Los afroamericanos tenfan menos probabilidad que los blancos de utilizar cualquier medicamento para dormir (25% vs 35%; p < 0.001), medicamentos para dormir de receta (14% vs 19%; p = 0.003), y medicamentos para dormir sin receta (10% vs 13%; p = 0.048). Estas diferencias raciales persistieron en los modelos multivariados. En el an^lisis estratificado por genera hubo una diferencia racial significativa en la utilization de medicamentos para dormir s61o entre las mujeres. CONCLUSIONES: Los afroamericanos tienen menor probabilidad que los blancos de reportar el uso actual de medicamentos para dormir con o sin receta. Estos resultados parecen ser mayormente debido a diferencias raciales entre las mujeres. Otros estudios de investigaci6n deben evaluar los factores fundamentales y si estas diferencias raciales impactan los resultados clfnicos. METHODOLOGIE: Les 1910 participants de cette etude (dont 69% sont de sexe feminin, 34% d'origine africaine et 66% blanc) sont des individus de l'&at de la Caroline du Nord faisant deja partie d'un projet observationnel d'arthrose de la hanche et du genou. Differentes informations ont ete colligees pour cette etude transversale dont notamment le type de medicaments utilises pour traiter les troubles de sommeil (medicaments disponibles sous prescription, medicaments en vente libre, produits naturels et autres produits). Des analyses de regression logistique multivariee ont ete effectuees pour controler differentes variables (age, sexe, education, assurance-sante, arthrose symptomatique de la hanche ou du genou, symptomes depressifs, oWsite, etat de sante general, troubles de sommeil [jours/annee]). Les modeles ont ete applique's sur l'ensemble de la population a l'etude ainsi que sur les hommes et les femmes de fa?on separee.
RESULTATS: Parmi tous les participants qui avaient rapporte des troubles de sommeil, pres du tiers utilisaient un ou plusieurs agents tWrapeutiques. Pres de 17% utilisaient des medicaments requdrant une prescription medicale, 12% des medicaments en vente libre, 1% des produits naturels et 3% des produits autres. Les Americains d'origine africaine consommaient globalement moins de somniferes que les Americains blanc (25% vs 35%, p < 0.001), moins de medicaments de prescription (14% vs 19%, p = 0.003) et moins de medicaments en vente libre (10% vs 13%, p = 0.048). Les analyses stratifiees ont permis d'identifier une difference significative quant a l'utilisation de somniferes chez les femmes. CONCLUSIONS: Les Americains de souche africaine ont moins tendance k utiliser des medicaments sous prescription et des medicaments en vente libre pour traiter leurs troubles de sommeil comparativement aux Americains blanc. Ces observations sont largement expliquees par les differences existant entre les femmes des 2 groupes. Des etudes additionnelles sont toutefois requises pour identifier les causes sousjacentes de ces differences et pour documenter si de telles differences raciales ont un impact sur les parametres cliniques.
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